ArticleMetabolism open2025
Synthetic target trial emulation and predictive modeling of amylin-pathway therapies for obesity and type 2 diabetes.
Faisal A Al-Harbi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it